ID
16921
Beschrijving
Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00220155
Link
https://clinicaltrials.gov/show/NCT00220155
Trefwoorden
Versies (1)
- 14-08-16 14-08-16 -
Geüploaded op
14 augustus 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Colorectal Cancer NCT00220155
Eligibility Colorectal Cancer NCT00220155
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
medical or psychiatric condition that comprise the patient's ability to take informed consent.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009488
- UMLS CUI [2]
- C0004936
- UMLS CUI [3]
- C0021430
Beschrijving
chemotherapy or radiotherapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C1522449
Beschrijving
gemcitabine
Datatype
boolean
Alias
- UMLS CUI [1]
- C0045093
Beschrijving
uncontrolled cerebral metastases
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0220650
- UMLS CUI [1,2]
- C0205318
Similar models
Eligibility Colorectal Cancer NCT00220155
- StudyEvent: Eligibility
C1319315 (UMLS CUI [1,2])
C0677984 (UMLS CUI [1,2])
C0009402 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
C1514457 (UMLS CUI [3])
C0040405 (UMLS CUI [1,2])
C0518015 (UMLS CUI [2])
C0005821 (UMLS CUI [3])
C0023508 (UMLS CUI [4])
C0200633 (UMLS CUI [5])
C0205318 (UMLS CUI [1,2])
C0004936 (UMLS CUI [2])
C0021430 (UMLS CUI [3])
C1522449 (UMLS CUI [2])
C0205318 (UMLS CUI [1,2])